Rieske-type oxygenases are promising biocatalysts for the destruction of persistent pollutants or for the synthesis of fine chemicals. In this work, we explored pathways through which Rieske-type oxygenases evolve to expand their substrate range. BphAE p4 , a variant biphenyl dioxygenase generated from Burkholderia xenovorans LB400 BphAE LB400 by the double substitution T335A/F336M, and BphAE RR41 showed that the single T335A and the double N338Q/L409F substitutions contribute significantly to enhanced catalytic activity toward dibenzofuran. Analysis of crystal structures showed that the T335A substitution relieves constraints on a segment lining the catalytic cavity, allowing a significant displacement in response to dibenzofuran binding. The combined N338Q/L409F substitutions alter substrate-induced conformational changes of protein groups involved in subunit assembly and in the chemical steps of the reaction. This suggests a responsive induced fit mechanism that retunes the alignment of protein atoms involved in the chemical steps of the reaction. These enzymes can thus expand their substrate range through mutations that alter the constraints or plasticity of the catalytic cavity to accommodate new substrates or that alter the induced fit mechanism required to achieve proper alignment of reactioncritical atoms or groups.
, Val
341 , and Phe 409 , metabolize dibenzofuran two and three times faster than BphAE LB400 , respectively. Steady-state kinetic measurements of single-and multiple-substitution mutants of BphAE LB400 showed that the single T335A and the double N338Q/L409F substitutions contribute significantly to enhanced catalytic activity toward dibenzofuran. Analysis of crystal structures showed that the T335A substitution relieves constraints on a segment lining the catalytic cavity, allowing a significant displacement in response to dibenzofuran binding. The combined N338Q/L409F substitutions alter substrate-induced conformational changes of protein groups involved in subunit assembly and in the chemical steps of the reaction. This suggests a responsive induced fit mechanism that retunes the alignment of protein atoms involved in the chemical steps of the reaction. These enzymes can thus expand their substrate range through mutations that alter the constraints or plasticity of the catalytic cavity to accommodate new substrates or that alter the induced fit mechanism required to achieve proper alignment of reactioncritical atoms or groups.
Rieske-type oxygenases (ROs) 3 catalyze a stereospecific oxygenation of many aromatic and hetero-aromatic molecules. These enzymes have potential applications as biocatalysts to degrade persistent pollutants, such as polyaromatic hydrocarbons (1, 2) , polychlorinated biphenyls (3) (4) (5) , and chlorodibenzofurans (6, 7), or to produce chiral arene cis-dihydrodiols of interest in enantioselective syntheses for the manufacture of fine chemicals (8 -10) . Biphenyl dioxygenase, one of the most extensively studied ROs, catalyzes the first reaction of the bacterial biphenyl catabolic pathway. Biphenyl dioxygenase has three components: the iron-sulfur oxygenase (hereinafter referred to as BphAE), a heterohexamer comprised of three ␣ (M r ϭ 51,000) and three ␤ (M r ϭ 22,000) subunits; the ferredoxin (BphF, M r ϭ 12,000); and the ferredoxin reductase (BphG, M r ϭ 43,000). The encoding genes for Burkholderia xenovorans LB400 (11) , which is the best polychlorinated biphenyl degrader of natural origin, are bphA (BphAE LB400 ␣ subunit), bphE (BphAE LB400 ␤ subunit), bphF (BphF LB400 ), and bphG (BphG LB400 ) (see Fig. 1 ).
BphAE LB400 has been thoroughly investigated because it can oxygenate a broad range of substrates. BphAE LB400 variants with extended substrate range have been generated by site-directed mutagenesis (12) and directed evolution (13, 14) . However, the enzyme's structural features that modulate substrate range and catalytic efficiency have yet to be determined. Many investigations have identified residues in contact with the substrate, or removed from it, as key determinants of substrate preference and regiospecificity (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Recently Thr 335 of BphAE LB400 , which is removed from the substrate, was found to restrain the range of chlorobiphenyls the enzyme can oxidize by controlling the spatial distribution of protein atoms in contact with the substrates (17) . Changing Thr 335 to Ala relieves intramolecular constraints on Gly 321 , allowing for significant movement of this residue during substrate binding, thereby increasing the space available to accommodate the bulkier substrate 2,6-dichlorobiphenyl. In addition, crystal structures of the oxygenase component of carbazole 1,9a-dioxygenase and of the binary complex of the oxygenase and ferredoxin components provided evidence that conformational changes are required to suitably align the Rieske clusters of the ferredoxin and oxygenase components (24) . These observations are consistent with a mechanism whereby an induced fit process is involved in RO substrate binding and catalytic function. Understanding how conformational adjustments influence the turnover rate and how they can be modified to enhance activity toward new substrates will aid the development of new, better performing catalysts.
Unlike biphenyl, the fused rings of dibenzofuran are locked in a co-planar conformation (Fig. 1) , and this molecule is poorly oxygenated by BphAE LB400 (25, 26 . BphAE RR41 was selected by directed evolution for its higher turnover rate with dibenzofuran than the parent BphAE p4 (7) . The library was produced by changing Asn 338 and Ile 341 of BphAE p4 simultaneously by saturation mutagenesis (7), but an additional spontaneous mutation L409F occurred in this mutant.
In this study, to gain more insight into the pathways through which ROs evolve to expand their substrate range, we identified the mutations in BphAE p4 and in BphAE RR41 that contribute most to their enhanced activity toward dibenzofuran and analyzed the crystal structures of BphAE RR41 and its dibenzofuranbound form to evaluate the consequences of the mutations.
EXPERIMENTAL PROCEDURES
Strains and Plasmids-Escherichia coli DH11S (27) and C41(DE3) (28) (Statagene, La Jolla, CA) were used in this study. The WT BphAE LB400 and its mutants BphAE p401 (T335A), BphAE p402 (F336M), BphAE p4 (T335A/F336M), and BphAE RR41 (T335A/F336M/N338Q/I341V/L409F) were described previously (17) .
A previously described two-step site-directed mutagenesis protocol (7) was used to create a set of mutants representing the six mutants that can be produced by single and double substitutions of N338Q, I341V, and L309F of BphAE p4 (Table 1) . These bphAE mutants were cloned in pQE31 or in pET14b.
DNA protocols were generally according to Sambrook et al. (29) . DNA from each mutant was sequenced at the Genome Quebec DNA Sequencing Center (Montreal, Canada). Biphenyl and dibenzofuran were of the highest purity grade available from AccuStandard (New Haven, CT).
Protein Analysis-The level of expression of each variant enzyme in IPTG-induced E. coli DH11S pDB31[LB400-bphFG] ϩ pQE31 [bphAE] was assessed by SDS-PAGE (30) of crude cell extracts prepared under benign (cells were sonicated in 10 mM phosphate buffer, pH 7.3, containing 140 mM NaCl) or denaturating conditions (cells were sonicated in 10 mM phosphate buffer, pH 7.3, containing 140 mM NaCl and 8 M urea). The gels were stained with Coomassie Brilliant Blue. Purified enzyme preparations were also analyzed by HPLC gel filtration chromatography using a Waters Protein Pak 300 SW column (7.8 ϫ 300 mm), as described previously (31) .
Monitoring Enzyme Activity with Purified Enzyme Preparations-Reconstituted His-tagged purified biphenyl dioxygenase preparations were used to monitor enzyme activity and metabolite production. In this case, the genes expressing each enzyme component were cloned into pET-14b (Novagen, Madison, WI) and expressed in E. coli C41(DE3). The components were produced as recombinant His-tagged protein and purified by affinity chromatography on high performance nickel-Sepharose resin (GE Healthcare) (7) . The concentration of each purified component was determined by spectrophotometry (31) (32) (33) . Enzymatic reactions were performed as described previously (7) at 37°C, in 50 mM pH 6.0 MES buffer, and in a volume of 400 l containing 1.2 nmol of each of the His-tagged enzyme component and 200 nmol of NADH. Substrate depletion and metabolite production were analyzed and quantified by GC-MS using previously published protocols (7) . The steady-state kinetic parameters of all BphAEs were determined by recording oxygen consumption rates using a Clarke-type Hansatech model DW1 oxygraph (34) for concentrations of biphenyl and dibenzofuran varying between 5 and 150 M. Kinetic parameters reported in this investigation were obtained from analysis of at least two independently produced preparations tested in triplicate.
Crystal Structure Analyses-Purification, crystallization, and preliminary x-ray diffraction properties of BphAE RR41 have been communicated elsewhere (35) . The procedures to prepare crystals of BphAE RR41 and its dibenzofuran-bound form were identical to those described for BphAE p4 (17) . The crystal struc- 
a All other residues for these variants are identical to those of BphAE LB400 .
tures were obtained and analyzed using the same approaches and software used in studies of BphAE p4 (17) . Crystal structures of BphAE RR41 and its dibenzofuran-bound form were compared with crystal structures of BphAE LB400 (RCSB Protein Data Bank accession code 2XR8) and its biphenyl-bound form (code 2XRX), as well as BphAE p4 (code 2XSO) and its 2,6-dichlorobiphenyl-bound form (code 2XSH).
Protein Data Bank Accession Codes-The coordinates have been deposited with the RCSB Protein Data Bank under accession codes 2YFI for BphAE RR41 and 2YFJ for its complex with dibenzofuran.
RESULTS

Steady-state Kinetics of BphAE p4 , BphAE RR41 , and Their
Variants with Dibenzofuran-Based on the sum of areas under GC-MS peaks of metabolites produced when 1.2 nmol of enzyme was incubated for 2 min with 100 M dibenzofuran, BphAE p4 and BphAE RR41 produced, respectively, three and four times more metabolites than BphAE LB400 (Fig. 2) . Consistent with the single time point measurements, the apparent k cat value for BphAE RR41 is ϳ1.5 times higher than that of BphAE p4 and 3 times higher than for BphAE LB400 based on the oxygen consumption rates recorded for variable concentrations of dibenzofuran (Table 2) . These results show the superior ability to metabolize dibenzofuran of BphAE RR41 compared with BphAE p4 and BphAE LB400 .
To identify the mutations that contribute most to the enhanced activity of BphAE p4 and BphAE RR41 toward dibenzofuran, we assayed all mutants carrying single or multiple mutations at positions 335, 336, 338, 341, and 409 (Table 1) . Based on the sum of areas under GC-MS peaks, the amounts of metabolites produced by the T335A mutant and by BphAE p4 (T335A/ F336M) were similar and about three times higher than the amounts for BphAE LB400 and its F336M mutant (Fig. 2) . The superior ability of the T335A mutant to metabolize dibenzofuran was confirmed by steady-state kinetics (Table 2) . Furthermore, the single F336M substitution lowered k cat and k cat /K m for the reaction with biphenyl. This identified the T335A substitution as responsible for the enhanced ability of BphAE p4 to metabolize dibenzofuran.
The apparent k cat values for the mutants T335A/F336M/ I341V and T335A/F336M/I341V/L409F toward biphenyl and dibenzofuran were lower than for BphAE p4 . In addition, introducing the single I341V or the double I341V/L409F mutations FIGURE 2. GC-MS spectra showing the relative amounts of the dihydrodihydroxy metabolites produced from dibenzofuran by BphAE LB400 and its variants. 1.2 nmol of each purified enzyme preparation was incubated for 2 min under the conditions described under "Experimental Procedures." The metabolites were extracted and derivatized with butylboronate before analysis by GC-MS.
TABLE 2 Steady-state kinetic parameters of BPDO variants
The steady-states kinetics were determined from the oxygen consumption rates as described under "Experimental Procedures." into BphAE p4 did not contribute to enhanced activity toward dibenzofuran. We did not determine steady-state kinetic parameters for variant T335A/F336M/L409F. However, the observation that recombinant E. coli cells producing this enzyme did not degrade dibenzofuran more efficiently than BphAE p4 (not shown) indicates that changing Leu 409 of BphAE p4 to Phe did not influence activity toward dibenzofuran. Variants T335A/F336M/N338Q and T335A/F336M/N338Q/ I341V were poorly active toward biphenyl and dibenzofuran because they are not assembled correctly (see below). The steady-state kinetic parameters obtained with these two variants were too difficult to determine accurately and therefore are not reported here. On the other hand, the apparent k cat value for T335A/F336M/N338Q/L409F toward dibenzofuran was in the same range or even higher than for BphAE RR41 (T335A/ F336M/N338Q/I341V/L409F) ( RR41 and T335A/F336M/N338Q/ L409F, variants T335A/F336M/N338Q and T335A/F336M/ N338Q/I341V were poorly active, which suggests a detrimental effect of the N338Q substitution on enzyme activity. When the proteins of IPTG-induced recombinant E. coli cells producing variant BphAEs were extracted under denaturing conditions and separated by SDS-PAGE, the intensities of bands corresponding to the ␣ and ␤ subunits were similar for all strains (Fig. 3A ). This shows that the level of expression of BphAE is similar for all IPTG-induced E. coli clones expressing these variants. However, analysis of cell extracts prepared under nondenaturing conditions revealed significantly lower intensities of the bands corresponding to the ␣ subunits for variant T335A/ F336M/N338Q and T335A/F336M/N338Q/I341V compared with the other variants (Fig. 3B ). This suggests misassembly or early dissociation of ␣ 3 ␤ 3 hexamers resulting in a loss of ␣ subunits into the nonsoluble protein fraction. HPLC gel filtration analysis of freshly purified His-tagged BphAE of variants T335A/F336M/N338Q and T335A/F336M/N338Q/I341V confirmed that less than 10% of each protein preparation exhibited the expected ␣ 3 ␤ 3 association pattern (not shown). Therefore, the N338Q substitution hinders hexamer assembly unless a concomitant L409F substitution is introduced. Nevertheless, the double N338Q/L409F substitution is beneficial for enhancing catalytic properties toward dibenzofuran.
Overall Structure of BphAE RR41 -The overall structures of BphAE RR41 and its dibenzofuran-bound form are very similar to the crystal structures of the BphAE p4 :2,6-dichlorobiphenyl complex (17) , which contains triplets of ␣␤ dimers associated into two hexamers in the asymmetric unit (chains ABCDEF and chains GHIJKL). For both structures, the final refined models contain residues Asn 18 to Phe 143 plus Phe 153 to Pro 459 of each ␣ subunit, residues Phe 9 to Phe 188 of each ␤ subunit and 1217 water molecules. The diffraction data and refined models are characterized in Table 3 .
Superposition of all C ␣ atoms for the ␣␤ dimer of chains AB with chains CD-KL yielded rmsd values of 0.2-0.3 Å. The poorly ordered residues and protein segments were the same as observed for BphAE p4 (17) , including segments comprising residues Ile 247 to Lys 263 and Glu 280 to Val 287 of the ␣ subunit and residues 9 -17 and 158 -164 of the ␤ subunit. In the BphAE RR41 -dibenzofuran complex structure, dibenzofuran could be identified clearly in F o Ϫ F c difference Fourier maps in all active sites of the ABCDEF hexamer. Similar to BphAE LB400 -biphenyl, a water molecule lies between the Fe 2ϩ and dibenzofuran at ϳ2 Å from the catalytic iron. Electron density maps of the active site residues of the BphAE RR41 and of its dibenzofuran-bound form are shown for dimer AB in Fig. 4 .
When the BphAE RR41 -dibenzofuran BphAE LB400 -biphenyl structures are superposed, the positions of the carbons targeted for hydroxylation, C-4a and C-4 of dibenzofuran and C-2 and C-3 of biphenyl, are nearly the same in ␣␤ dimers AB, CD, and EF (not shown). In ␣␤ dimers AB, CD, and EF of BphAE RR41 -dibenzofuran, the substrate is in an orientation that would favor 4,4a angular attack. This is unexpected because biochemical data revealed dioxygenation of the lateral 1,2 and 3,4 carbons of dibenzofuran as by far most favored for BphAE RR41 (7) . In the crystal structure, the furan ring's oxygen atom contacts the water ligand of the active site Fe 2ϩ atom. Based on observations drawn from the naphthalene dioxygenase crystal structure, Karlsson et al. (36) proposed a reaction cycle for ROs in which Fe 2ϩ coordinates this water in states prior to dioxygen binding. When dioxygen binds, it intercalates side-on between the iron and the substrate displacing the water. Thus, a subsequent adjustment in substrate position or orientation is possible such that the lateral attack would occur. In essence, the dibenzofuran-O-water interaction seen in the crystal form could produce a false inference about the points of attack because the structure reports on a state prior to dioxygen binding. (Fig. 5) . However, the overall shape of the cavity of BphAE RR41 -dibenzofuran differs significantly from that of BphAE LB400 -biphenyl but is similar to that of BphAE p4 :2-chlorobiphenyl (Fig. 5) . This is caused principally by the replacement of Phe 336 by Met combined with the conformational freedom of Gly 321 . The new catalytic properties of BphAE p4 toward dibenzofuran (and in part those of BphAE RR41 ) can thus be attributed to structural changes in the distal portion of the substrate-binding pocket. As noted for BphAE p4 , the T335A mutation relieves constraints on the Val 320 :Gln 322 segment, allowing 
displacement of the Gly 321 carbonyl such that it moves away from the substrate (17) . In this case, the removal of Gly 321 from dibenzofuran reduces the influence it exerts on the distal ring of the substrate. This is significant because dibenzofuran is obligatory co-planar: an altered placement of the distal ring would influence the orientation of the proximal ring inside the catalytic pocket.
Structural Analysis of the Influence of Residues 338 and 409 on Enzyme Stability-Based on the crystal structure of BphAE RR41 , as well as the structures of BphAE LB400 and BphAE p4 (17) , Gln 338 and Phe 409 are too distant from each other to interact. To understand the effect of these two mutations,we need to examine closely the overall structure of the ␣ and ␤ subunits and the contacts at the ␣␣, ␤␤, and ␣␤ interfaces.
The overall crystal structure of the ␤ subunit of BphAE RR41 is very similar to that of other biphenyl dioxygenases (16, 17) and naphthalene dioxygenase (2) . It includes a long twisted sixstranded ␤ sheet, with three helices on the inward side of the sheet and a loop made of residues 9 -20 ( Fig. 6A) on its outward side. Many polar interactions are uniformly distributed between the ␤-sheet residues of vicinal ␤ subunits and between two of the helices and ␤-sheet residues of the vicinal subunit. In addition, helix ␣3 and strand ␤2 are in contact with the ␣ subunit. This suggests that the ␤ subunit plays a key role in subunit assembly.
As reported for other dioxygenases (2, 16), the ␣ subunit comprises two domains: the Rieske and catalytic domains. Unlike the ␤ subunits, the crystal structures show unevenly distributed contacts between vicinal ␣ subunits; these contacts occur principally at the junction between the Rieske domain of one ␣ subunit and the catalytic domain of its vicinal subunit (Fig. 6A) .
The Rieske domain is dominated by antiparallel ␤ strands from which two hairpin structures protrude to form two fingers that hold the [2Fe-2S] center. The catalytic domain contains the catalytic Fe 2ϩ , which lies against a eight-stranded antiparallel ␤ sheet on one side and is surrounded on the other sides by helices and loops (Fig. 6B) (Fig. 6C) . Therefore, the crystal structures show that residue Phe 409 is located within a stretch of amino acids that appears to play an important role in subunit assembly and/or in maintaining the stability of the oligomeric structure. In BphAE RR41 , Phe 409 is ϳ4.6 Å from Phe 222 of helix ␣6 (Fig. 6C) (12) (13) (14) . This region includes a loop between strands ␤18 and ␤19 and a portion of strand ␤19. Residues 338 and 341 are both located on strand ␤19 (Fig. 6C) and Asp 230 , two residues believed to be involved in the reaction mechanism (36, 38) and found in the catalytic cavity at the level of the proximal ring of the substrate (17) (Fig. 6B) , and the latter forms two polar contacts with Glu 385 of helix ␣12. Arg 340 is also close enough to Glu 385 to form a salt bridge with this residue (Fig. 6C) (Fig. 7) . This movement is likely required to suitably align the reactive atoms for progression along the chemical reaction.
In ROs, the proximity between the Rieske cluster and the iron in the active site of the adjacent ␣ subunit is consistent with a mechanism involving a transfer of electron across the interface between two subunits (2, 16, 17) . This is corroborated by the fact that full activity requires that ␣ and ␤ subunits associate into a ␣ 3 ␤ 3 configuration (31) . Such a mechanism must demand precise alignment of the amino acids involved in electron transfer between the Rieske cluster and the mononuclear iron of each adjacent ␣ subunit, highlighting the importance of the protein atoms involved in the ␣␣ subunit interface.
Therefore, crystal structure analysis is consistent with an induced fit response required to reorganize the active site and facilitate the interplay between protein atoms critical for the reaction. The N338Q substitution might disturb the conformation of helices ␣12 and ␣6, resulting in subunit instability or misassembly. Conversely, the double Gln 338 and Phe 409 mutation may affect the conformational fluctuations of these helices in such a way that it enhances the roles of protein residues such as Asn 388 , Gln 226 , and Asp 230 that are located on the helices and presumed to be involved in the chemical steps of the reaction (2, 38) .
DISCUSSION
In this study, we examined the crystal structure of BphAE RR41 , an evolved RO that oxidizes dibenzofuran more efficiently than its BphAE LB400 and BphAE p4 parents. Despite the limitations of crystal structure analyses, the study revealed two pathways through which ROs evolve to expand their substrate range.
Traditionally, enzyme engineering to alter the substrate range involves mutations at residues lining the catalytic pocket. This approach has been applied successfully in many circumstances (39 -45) . Reducing the size of a side chain or altering charge distributions can generate enzyme with new catalytic properties.
However, other studies have shown that several residues not in direct contact with the substrate can significantly change the catalytic properties of biphenyl dioxygenase toward biphenyl analogs (21, 22, 44) . In this work we confirm the importance of the T335A mutation. In altering the plasticity of the catalytic cavity, this mutation allows the carbonyl of residue Gly 321 to move away from the substrate. In a previous work, we showed that this movement was required to increase the space available and gray) protrude into a matching trough of the vicinal catalytic domain of monomer C. The residues from monomer C that contact the hairpins from the vicinal subunit are colored in blue or gray to match the residues they contact. FIGURE 7. Superposition of residues of the catalytic domain that move after substrate binding. A, residues of BphAE RR41 (red) and BphAE RR41 -dibenzofuran (green). B, residues of BphAE LB400 (brown) and BphAE LB400 -biphenyl (yellow). C, residues of BphAE p4 (gray) and BphAE p4 :2,6-dichlorobiphenyl (purple).
to bind the bulky 2,6-dichlorobiphenyl in a productive orientation (17) . Because dibenzofuran is obligatory co-planar, any misplacement of the distal ring would influence the orientation of the proximal ring inside the catalytic pocket. Therefore, consistent with an induced fit mechanism, in BphAE p4 and BphAE RR41 , the displacement of Gly 321 appears to be required to reduce the influence it exerts through atomic interactions on the substrate's distal ring.
In this work, we highlighted a second and more subtle route to changes in substrate range, which implies that in ROs, either one or both of the induced fit or protein dynamic processes are involved to place the protein atoms involved in the reaction into proper relationships that facilitate catalysis. The reaction catalyzed by ROs is complex; it not only involves substrate binding and release of product, but also one dioxygen molecule is required in the reaction, and electrons must be transferred from the ferredoxin component to the Rieske cluster of one ␣ subunit and then to the catalytic iron of the vicinal ␣ subunit. Furthermore, a recent report showed residues at the interface between the Rieske domain and the catalytic domain move during formation of the complex between the oxygenase and ferredoxin components of carbazole 1,9a-dioxygenase (24) . This implies that reaction-critical atoms from the Rieske domain must align properly with those of the vicinal catalytic domain, and the reaction-critical atoms of the catalytic domain must align properly to work together during the catalytic process. Structural analysis shows that residues located on secondary structures ␣6 and ␣12 are involved in subunit assembly, and biochemical data suggest that they are involved in the catalytic reaction (electron transfer and protonation) (2, 38) . The fact that these residues move during substrate binding is consistent with a substrate-induced retuning process required to suitably align the protein atoms involved in the chemical steps of the reaction. In such a context, by altering the interactions occurring between secondary structure elements surrounding the catalytic center, the N338Q mutation generates a protein unable to stabilize the ␣ 3 ␤ 3 assembly previously shown to be required for activity (31) . However, the double N338Q and L409F substitution generates an ␣ subunit that supports a stable hexamer and where the retuning process is improved compared with its BphAE LB400 and BphAE p4 parents, resulting in a more efficient and faster catalytic reaction. ROs can thus be engineered to enhance their catalytic properties toward new substrates by altering the process involved in fine-tuning the interplay between the reaction-critical atoms.
Many questions remain unanswered; crystal structure analysis did not determine a clear-cut mechanism by which the double N338Q/L409F substitution affects the enzyme structure and catalytic properties, and our data do not determine which of the enzymatic steps are accelerated during the reaction. Although the data do not provide any direct demonstration that the N338Q and L409F substitutions either affect an induced fit or protein dynamic mechanism involved in the catalytic reaction, it is clear from crystal structure analysis that these residues occupy strategic positions whereby they can interact with reaction-critical protein atoms/groups and affect oligomeric assembly. Furthermore, residues of helix ␣12 and ␣6, and especially Asp 388 and Gln 226 , which are postulated to play a key role in the catalytic reaction (36) , moved significantly during substrate binding in all variants (BphAE LB400 , BphAE p4 , and BphAE RR41 ). Altogether, our analysis shows that evolving ROs to change their substrate specificity is a rather complex enterprise that does not exclusively involve mutations at key residues in direct contact with the substrate. It appears that some mutations affect key residues associated with necessary conformational changes that are more difficult to identify by a rational approach but that are required to allow productive or improved interplay of reaction-critical atoms both inside and outside the substrate-binding pocket.
